Pure One™ Next Gen Plant Based Omega-3™ was developed for use in our scientifically optimized Omega-3 DHA Therapy™ program. This three month dosing program helps the body on its way to improved health by doubling circulating Omega-3 levels.
Omega-3 DHA Therapy™ is a dosing program that helps lower silent inflammation levels in the body. The figure below shows how to reach an ideal omega-3 sufficiency.
Our program guarantees you will eliminate Omega-3 deficiency in three months or less. Many suffer from low omega-3 levels in the body. The three month program is standardized to provide greater than 1 gram of bioavailable omega-3 DHA daily.* See Ingredients.
FIGURE: The general population usually has an average 4% RBC (Red Blood Cell membrane) omega-3 levels (low bar). A standard dosing strategy with 600 mg DHA + 10 mg EPA is recommend to end omega-3 deficiency (medium bar). The therapeutic dosing strategy of 1200 mg DHA + 20 mg EPA for three months helps you achieve omega-3 sufficiency (ideal bar).
8% RBC membrane levels is about as high as your body will go. After 3 months a minimum maintenance dose at 600 mg DHA + 10 mg EPA is suggested. Continuing at 1200 mg DHA is also an option for long term care therapy programs.
Pure One™ is exclusively used in the Omega-3 DHA Therapy™. Our mission is to deliver measurable results.
DIRECTIONS: For the first 3-months take 4 softgels per day (4 in the morning or 2 in the morning and 2 at night). After 3 months, individuals may reduce to 2 softgels per day for maintenance to continue.
OMEGA-3 DEFICIENCY NEWS
Omega-3 Deficiency causes 96,000 US deaths per year, say researchers
By Shane Starling, 26-Jun-2009
Related topics: Omega-3, Research, Nutritional lipids and oils, Cardiovascular health, Cognitive and mental function
Omega-3 deficiency is the sixth largest killer of Americans and more deadly than excess trans fat intake, according to a new study.
The Harvard University researchers looked at 12 dietary, lifestyle and metabolic risk factors such as tobacco smoking and high blood pressure and used a mathematical model to determine how many fatalities could have been prevented if better practices had been observed.
The study, jointly funded by the Centers for Disease Control and Prevention (CDC) through the Association of Schools of Public Health, drew on 2005 data from the US National Health Center for Health Statistics. They determined that there were 72,000-96,000 preventable deaths each year due to omega-3 deficiency, compared to 63,000-97,000 for high trans fat intake. [More]
OMEGA-3 DHA THERAPY™ ends potential docosahexaenoic acid and/or omega-3 deficiencies and supports cardiovascular, metabolic and cognitive health management for optimal wellness during the aging process. DHA is increasingly considered more essential for proper long-term care.***
***OMEGA-3 DHA THERAPY™ is considered a protective strategy for brain, eye and heart health. It is not presently a prevention, treatment or a cure for any condition-specific disease.
OMEGA-3 DHA THERAPY™ ideally helps eliminate risks due to inflammation and deficiency.
* Information and statements regarding this supplement have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.
© 2010-2013 SOURCE-OMEGA, LLC.
All Rights Reserved.